|
Incontinence Quality of Life questionnaire: subscale scores. |
||||||||||||||
| I-QOL Avoidance and Limiting Behavior Subscale Score |
I-QOL Psychological Impact Subscale Score |
I-QOL Social Embarrassment Subscale Score |
||||||||||||
|
|
||||||||||||||
| Treatment group (N)† |
Time point |
n‡ |
Mean I-QOL |
Mean change in I-QOL from baseline§ |
95% CI for treatment difference in I-QOL¶ |
P |
Mean I-QOL |
Mean change in I-QOL from baseline§ |
95% CI for treatment difference in I-QOL¶ |
P |
Mean I-QOL |
Mean change in I-QOL from baseline§ |
95% CI for treatment difference in IQOL¶ |
P |
|
|
||||||||||||||
| Placebo (61) |
Baseline |
59 |
62.34 |
(-5.26,6.46) |
64.22 |
(-3.73,7.89) |
54.07 |
(-7.37,6.82) |
||||||
| Endpoint |
75.16 |
12.82 |
76.22 |
12.01 |
70.59 |
16.53 |
||||||||
| Duloxetine (60) |
Baseline |
52 |
63.28 |
66.72 |
54.33 |
|||||||||
| Endpoint |
75.96 |
12.68 |
.839 |
79.65 |
12.93 |
.480 |
70.77 |
16.44 |
.940 |
|||||
|
†N = number randomized. ‡n = number with diary data available for specified analysis. §Baseline is the last nonmissing visit score on or before randomization. ¶95% CI for treatment difference. Abbreviations: CI = confidence interval; I-QOL = Incontinence Quality of Life questionnaire | ||||||||||||||
Lin et al. BMC Urology 2008 8:2 doi:10.1186/1471-2490-8-2 |
||||||||||||||